{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:16:07Z","timestamp":1778156167866,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006416","name":"State University of Campinas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clbc.2026.03.020","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:32:43Z","timestamp":1775151163000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uptake of Cascade Genetic Testing for Hereditary Breast Cancer in the Public Health System in a Middle-Income Country: A Real-World Study"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9079-3718","authenticated-orcid":false,"given":"Thiago","family":"Gaspar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Imbassahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Narciso","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Elisabete Rubio","family":"Alem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Elisa Ribeiro da Silva","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Regina Campos","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00eddia","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-460X","authenticated-orcid":false,"given":"Cesar","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2026.03.020_bib0001","series-title":"Estimativa 2023: Incid\u00eancia de C\u00e2ncer no Brasil","first-page":"160","year":"2022"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.020_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.020_bib0003","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1038\/s41598-022-07383-1","article-title":"Detection of germline variants in Brazilian breast cancer patients using multigene panel testing","volume":"12","author":"Guindalini","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.clbc.2026.03.020_bib0004","article-title":"Risk-reducing surgeries for breast cancer in Brazilian patients undergoing multigene germline panel: impact of results on decision making","author":"Duarte","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.03.020_bib0005","first-page":"1","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"1","author":"Kurian","year":"2017","journal-title":"JCO Precision Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.020_bib0006","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/genes14010106","article-title":"Frequency of pathogenic germline mutations in early and late onset familial breast cancer patients using multi-gene panel sequencing: an Egyptian study","volume":"14","author":"Nassar","year":"2023","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.020_bib0007","doi-asserted-by":"crossref","first-page":"100980","DOI":"10.1016\/j.gim.2023.100980","article-title":"Systematic evidence review and meta-analysis of outcomes associated with cancer genetic counseling","volume":"26","author":"Culver","year":"2024","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.020_bib0008","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/GRF.0000000000000895","article-title":"Uptake of cascade genetic testing for hereditary breast and ovarian cancer: a systematic review and meta-analysis","volume":"67","author":"Ahsan","year":"2024","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.020_bib0009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk Assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.020_bib0010","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/jgc4.1360","article-title":"Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting","volume":"30","author":"Lee","year":"2021","journal-title":"J Genet Couns"},{"key":"10.1016\/j.clbc.2026.03.020_bib0011","article-title":"Germline genetic testing in breast cancer: utilization and disparities in a middle-income country","volume":"11","author":"Souza","year":"2025","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.clbc.2026.03.020_bib0012","article-title":"Germline pathogenic variant prevalence among Latin American and US Hispanic individuals undergoing testing for hereditary breast and ovarian cancer: a cross-sectional study","volume":"8","author":"Ossa Gomez","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.020_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10689-018-0089-z","article-title":"The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice","volume":"18","author":"Menko","year":"2019","journal-title":"Fam Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2026.03.020_bib0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1025864703405","article-title":"Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway","volume":"12","author":"Bodd","year":"2003","journal-title":"J Genet Couns"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.020_bib0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/cge.12468","article-title":"Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas","volume":"88","author":"Trottier","year":"2015","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.clbc.2026.03.020_bib0016","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jmg.2005.039172","article-title":"Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder","volume":"43","author":"Suthers","year":"2006","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.020_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10689-015-9854-4","article-title":"The impact of an interventional counselling procedure in families with a BRCA1\/2 gene mutation: efficacy and safety","volume":"15","author":"Sermijn","year":"2016","journal-title":"Fam Cancer"},{"issue":"7","key":"10.1016\/j.clbc.2026.03.020_bib0018","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/pon.3187","article-title":"Valdimarsdottir HB. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City","volume":"22","author":"Sussner","year":"2013","journal-title":"Psychooncology"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.020_bib0019","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10897-016-0064-5","article-title":"Large prospective analysis of the reasons patients do not pursue BRCA genetic testing following genetic counseling","volume":"26","author":"Hayden","year":"2017","journal-title":"J Genet Couns"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:44:26Z","timestamp":1778154266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1526820926000522"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.020","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake of Cascade Genetic Testing for Hereditary Breast Cancer in the Public Health System in a Middle-Income Country: A Real-World Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}